LEMMY EGHAREVBA: Open Payments
NPI 1154168391 · CARPENTERSVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,275 in 54 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $94 · 2025 $1,275
Food & beverage: $1,275
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 12 | $334 |
| Otsuka America Pharmaceutical, Inc. | 15 | $328 |
| Lundbeck LLC | 12 | $215 |
| ABBVIE INC. | 5 | $117 |
| Neurocrine BioSciences, Inc. | 2 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $61 |
| Axsome Therapeutics, Inc. | 2 | $51 |
| Teva Pharmaceuticals USA, Inc. | 2 | $47 |
| Janssen Pharmaceuticals, Inc | 1 | $29 |
| Supernus Pharmaceuticals, Inc. | 1 | $25 |
Products named: REXULTI, HETLIOZ, VRAYLAR, INGREZZA, CAPLYTA, Auvelity, AUSTEDO XR, INVEGA SUSTENNA.
Industry payments across IL — which companies pay providers there.
